Cuu Long Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -4.67% vs 22.33% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -106.67% vs 12.88% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "324,121.50",
          "val2": "340,016.70",
          "chgp": "-4.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22,109.80",
          "val2": "55,503.20",
          "chgp": "-60.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "13,037.00",
          "val2": "10,129.10",
          "chgp": "28.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,677.20",
          "val2": "25,156.80",
          "chgp": "-106.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.10%",
          "val2": "127.50%",
          "chgp": "-10.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.13% vs 14.24% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -62.89% vs -12.86% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,321,589.10",
          "val2": "1,306,797.40",
          "chgp": "1.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "111,901.40",
          "val2": "98,087.70",
          "chgp": "14.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49,128.60",
          "val2": "25,494.50",
          "chgp": "92.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20,091.20",
          "val2": "54,145.50",
          "chgp": "-62.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.30%",
          "val2": "45.80%",
          "chgp": "-0.15%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

324,121.50

340,016.70

-4.67%

Operating Profit (PBDIT) excl Other Income

22,109.80

55,503.20

-60.16%

Interest

13,037.00

10,129.10

28.71%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-1,677.20

25,156.80

-106.67%

Operating Profit Margin (Excl OI)

25.10%

127.50%

-10.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -4.67% vs 22.33% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -106.67% vs 12.88% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,321,589.10

1,306,797.40

1.13%

Operating Profit (PBDIT) excl Other Income

111,901.40

98,087.70

14.08%

Interest

49,128.60

25,494.50

92.70%

Exceptional Items

0.00

0.00

Consolidate Net Profit

20,091.20

54,145.50

-62.89%

Operating Profit Margin (Excl OI)

44.30%

45.80%

-0.15%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 1.13% vs 14.24% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -62.89% vs -12.86% in Dec 2024

All Annual Results